Health In Tech, Inc. Class A Common Stock (HIT)
Official siteTECHNOLOGY • SOFTWARE - APPLICATION • NASDAQ
Market Cap: $25.83M
Last updated: Nov 17, 2026 at 11:00 AM ET
Health In Tech, Inc. Class A Common Stock (HIT) Financials: Revenue, Profit and Cash Flow
Health In Tech, Inc. Class A Common Stock reported revenue of $33.33M for the fiscal year ended Dec 31, 2025, up 71.0% from the year before. That year, net income was $1.28M with a net margin of 3.8%, operating cash flow was $3.13M and free cash flow was -$56.11K. The quarter ended Sep 30, 2026 had revenue of $6.59M and net income of -$7.11M.
Revenue and Margins
The operating margin was 4.6% in the fiscal year ended Dec 2025.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $33.33M | +71.0% | 62.8% | 4.6% | 3.8% |
| Dec 2024 | $19.49M | +1.8% | 79.2% | 5.1% | 3.4% |
| Dec 2023 | $19.15M | +231.9% | 88.0% | 17.7% | 20.7% |
| Dec 2022 | $5.77M | N/A | 94.2% | 3.6% | 1.4% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 90.9% from the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | $33.33M | $19.49M | $19.15M | $5.77M |
| Cost of revenue | $12.39M | $4.05M | $2.30M | $334.19K |
| Gross profit | $20.94M | $15.44M | $16.85M | $5.44M |
| Research and development | $1.57M | $2.81M | $2.00M | $794.62K |
| Operating income | $1.53M | $989.90K | $3.38M | $205.58K |
| Net income | $1.28M | $670.48K | $3.96M | $79.74K |
| EBITDA | $2.16M | $2.30M | $3.72M | $205.58K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.59M | $8.06M | $8.77M | $7.51M | $8.49M | $9.31M | $8.01M | $4.90M | $4.46M | $5.00M | $5.12M | $5.22M |
| Gross profit | $3.06M | $3.92M | $4.51M | $4.13M | $5.14M | $6.31M | $5.36M | $3.80M | $3.48M | $4.03M | $4.14M | $4.26M |
| Operating income | -$8.39M | -$3.44M | -$2.16M | -$170.81K | $493.52K | $725.07K | $480.66K | -$316.34K | $438.88K | $534.94K | $332.42K | $1.46M |
| Net income | -$7.11M | -$2.51M | -$1.59M | -$302.56K | $452.18K | $630.63K | $498.59K | -$144.15K | $376.09K | $338.01K | $100.54K | $1.00M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $0 by $7.67M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total assets | $23.09M | $15.77M | $11.50M | $28.56M |
| Current assets | $16.16M | $10.78M | $6.86M | $25.43M |
| Cash and equivalents | $7.67M | $7.85M | $2.42M | $1.49M |
| Total liabilities | $5.98M | $2.60M | $5.41M | $27.14M |
| Short-term debt | $0 | $66.88K | $1.65M | $50.72K |
| Shareholder equity | $17.11M | $13.17M | $6.09M | $1.05M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $28.03M | $29.63M | $28.97M | $23.09M | $22.76M | $22.18M | $21.33M | $15.77M | $9.67M | $10.76M | $10.44M | $11.50M |
| Total liabilities | $15.15M | $10.01M | $7.36M | $5.98M | $5.60M | $5.75M | $7.17M | $2.60M | $2.76M | $4.23M | $4.25M | $5.41M |
| Cash and equivalents | $10.13M | $6.51M | $10.33M | $7.67M | $8.02M | $8.14M | $7.58M | $7.85M | $1.75M | $2.16M | $1.36M | $2.42M |
| Shareholder equity | $12.85M | $19.55M | $21.60M | $17.11M | $17.16M | $16.42M | $14.16M | $13.17M | $6.91M | $6.53M | $6.19M | $6.09M |
Cash Flow
In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Operating cash flow | $3.13M | $2.18M | $1.53M | $782.75K |
| Capital expenditures | $3.19M | $900.75K | $1.14M | $1.22M |
| Free cash flow | -$56.11K | $1.28M | $384.52K | -$436.63K |
| Dividends paid | N/A | N/A | $44.35K | N/A |
| Investing cash flow | -$3.13M | -$836.75K | -$1.94M | -$1.22M |
| Financing cash flow | -$187.39K | $4.09M | $1.34M | $1.88M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.05M | -$2.91M | -$3.32M | $451.21K | $673.97K | $1.48M | $527.35K | -$531.17K | $2.12M | $1.27M | -$680.21K | -$405.58K |
| Capital expenditures | $842.16K | $596.99K | $362.13K | $831.71K | $744.84K | $909.90K | $703.48K | $606.12K | $67.28K | $93.96K | $133.39K | $277.65K |
| Free cash flow | -$1.89M | -$3.51M | -$3.68M | -$380.50K | -$70.87K | $571.38K | -$176.12K | -$1.14M | $2.05M | $1.17M | -$813.61K | -$683.23K |
Frequently Asked Questions About HIT
What is Health In Tech, Inc. Class A Common Stock's annual revenue?
Health In Tech, Inc. Class A Common Stock reported revenue of $33.33M for the fiscal year ended Dec 31, 2025.
How fast is Health In Tech, Inc. Class A Common Stock's revenue growing?
Revenue was up 71.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 79.4%.
Is Health In Tech, Inc. Class A Common Stock profitable?
Yes. Health In Tech, Inc. Class A Common Stock reported net income of $1.28M for the fiscal year ended Dec 31, 2025, with a net margin of 3.8%.
How much free cash flow does HIT generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $3.13M minus capital expenditures of $3.19M produced free cash flow of -$56.11K.
How much debt does Health In Tech, Inc. Class A Common Stock have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $0 and cash and equivalents of $7.67M.
HIT pages: Overview, Forecast, Financials, Valuation, Competitors